tiprankstipranks
Trending News
More News >
Lixte Biotechnology Holdings (LIXT)
NASDAQ:LIXT
US Market
Advertisement

Lixte Biotechnology Holdings (LIXT) Ownership - Who Owns Lixte Biotechnology Holdings?

Compare
88 Followers

Lixte Biotechnology Holdings (LIXT) Ownership Overview

4.62%0.75%4.99%0.18%89.46%
4.62%
Insiders
4.99% Other Institutional Investors
0.18% ETFs
89.46% Public Companies and
Individual Investors
The ownership structure of Lixte Biotechnology Holdings (LIXT) stock is a mix of institutional, retail, and individual investors. Approximately 5.92% of the company’s stock is owned by Institutional Investors, 4.62% is owned by Insiders, and 89.46% is owned by Public Companies and Individual Investors.
The ownership structure of Lixte Biotechnology Holdings (LIXT) stock is a mix of institutional, retail, and individual investors. Approximately 5.74% of the company’s stock is owned by Institutional Investors, 4.62% is owned by Insiders, and 0.18% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
74,804Insider2.58%246,853
52,632Insider1.82%173,686
16,529Institution0.57%54,546
6,300Insider0.22%20,790
5,209Institution0.18%17,190
5,209Institution0.18%17,190

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
16,529Institution0.57%54,546
5,209Institution0.18%17,190

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,209Institution0.18%6,147

FAQ

Who Owns Lixte Biotechnology Holdings (LIXT)?
According to the latest TipRanks data, approximately 4.99% of the company's stock is held by institutional investors, 4.62% is held by insiders, and 89.46% is held by retail investors.
    What percentage of Lixte Biotechnology Holdings (LIXT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 4.99% of Lixte Biotechnology Holdings (LIXT) stock is held by institutional investors.
      What percentage of Lixte Biotechnology Holdings (LIXT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 89.46% of Lixte Biotechnology Holdings (LIXT) stock is held by retail investors.
        Who owns the most shares of Lixte Biotechnology Holdings (LIXT)?
        Stephen J. Forman owns the most shares of Lixte Biotechnology Holdings (LIXT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis